Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy
Cardiovascular diseases (CVD) represent a substantial global health burden, leading to significant morbidity and mortality rates. However, the efficacy and safety of CVD therapies are markedly influenced by individual variability in drug responses and adverse reactions, often attributable to genetic...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/88382 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy
- Drug Interactions, Pharmacogenomics and Cardiovascular Complication
- Advanced Hepatitis Management: Precision Medicine Integration
- Introductory Chapter: Pharmacogenomics and Pharmacogenetics in Drug Therapy
- Gene Therapy Targets and the Role of Pharmacogenomics in Heart Failure
- Gene Therapy in Cardiovascular Disease
- The State of the Art: Pharmacogenomics, Multi-Omics, and Translational Barriers in Antipsychotic Therapy